Shannon M Bates

Summary

Affiliation: McMaster University
Country: Canada

Publications

  1. pmc Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol
    Pablo Alonso-Coello
    Iberoamerican Cochrane Centre, CIBERESP IIB Sant Pau, Barcelona, 08041, Spain
    BMC Pregnancy Childbirth 12:40. 2012
  2. doi request reprint Preventing thrombophilia-related complications of pregnancy: an update
    Shannon M Bates
    Department of Medicine, McMaster University and Thrombosis and Atherosclerosis Research Institute TaARI, Hamilton, ON, Canada
    Expert Rev Hematol 6:287-300. 2013
  3. doi request reprint D-dimer assays in diagnosis and management of thrombotic and bleeding disorders
    Shannon M Bates
    Department of Medicine, McMaster University and the Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada
    Semin Thromb Hemost 38:673-82. 2012
  4. pmc Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    Shannon M Bates
    Department of Medicine, McMaster University and Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada
    Chest 141:e351S-418S. 2012
  5. pmc VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    Shannon M Bates
    Department of Medicine, McMaster University and Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada
    Chest 141:e691S-736S. 2012
  6. ncbi request reprint Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    Shannon M Bates
    Department of Medicine, McMaster University and Henderson Research Centre, Hamilton, Ontario, Canada
    Chest 133:844S-886S. 2008
  7. doi request reprint Consultative hematology: the pregnant patient pregnancy loss
    Shannon M Bates
    Department of Medicine, McMaster University and Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada
    Hematology Am Soc Hematol Educ Program 2010:166-72. 2010
  8. ncbi request reprint A latex D-dimer reliably excludes venous thromboembolism
    S M Bates
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Arch Intern Med 161:447-53. 2001
  9. ncbi request reprint Imaging characteristics of a novel technetium Tc 99m-labeled platelet glycoprotein IIb/IIIa receptor antagonist in patients With acute deep vein thrombosis or a history of deep vein thrombosis
    Shannon M Bates
    Thromboembolism Unit Office, HSC 3W11, Department of Medicine, McMaster University Medical Centre, 1200 Main St W, Hamilton, Ontario, Canada L8N 3Z5
    Arch Intern Med 163:452-6. 2003
  10. ncbi request reprint Treatment and prophylaxis of venous thromboembolism during pregnancy
    Shannon M Bates
    Thromboembolism Unit Office, HSC 3W11, Department of Medicine, McMaster University Medical Centre, 1200 Main Street West, Hamilton, Ontario, Canada L8N 3Z5
    Thromb Res 108:97-106. 2002

Detail Information

Publications51

  1. pmc Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol
    Pablo Alonso-Coello
    Iberoamerican Cochrane Centre, CIBERESP IIB Sant Pau, Barcelona, 08041, Spain
    BMC Pregnancy Childbirth 12:40. 2012
    ..The values and treatment preferences of pregnant women, crucial when making recommendations for prophylaxis, are currently unknown. The objective of this study is to address this gap in knowledge...
  2. doi request reprint Preventing thrombophilia-related complications of pregnancy: an update
    Shannon M Bates
    Department of Medicine, McMaster University and Thrombosis and Atherosclerosis Research Institute TaARI, Hamilton, ON, Canada
    Expert Rev Hematol 6:287-300. 2013
    ....
  3. doi request reprint D-dimer assays in diagnosis and management of thrombotic and bleeding disorders
    Shannon M Bates
    Department of Medicine, McMaster University and the Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada
    Semin Thromb Hemost 38:673-82. 2012
    ..This article will review the available evidence for the utilization of D-dimer antigen measurement in the management of thrombotic and bleeding disorders...
  4. pmc Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    Shannon M Bates
    Department of Medicine, McMaster University and Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada
    Chest 141:e351S-418S. 2012
    ..This guideline focuses on the identification of optimal strategies for the diagnosis of DVT in ambulatory adults...
  5. pmc VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    Shannon M Bates
    Department of Medicine, McMaster University and Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada
    Chest 141:e691S-736S. 2012
    ..This guideline focuses on the management of VTE and thrombophilia as well as the use of antithrombotic agents during pregnancy...
  6. ncbi request reprint Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    Shannon M Bates
    Department of Medicine, McMaster University and Henderson Research Centre, Hamilton, Ontario, Canada
    Chest 133:844S-886S. 2008
    ....
  7. doi request reprint Consultative hematology: the pregnant patient pregnancy loss
    Shannon M Bates
    Department of Medicine, McMaster University and Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada
    Hematology Am Soc Hematol Educ Program 2010:166-72. 2010
    ....
  8. ncbi request reprint A latex D-dimer reliably excludes venous thromboembolism
    S M Bates
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Arch Intern Med 161:447-53. 2001
    ..D-Dimer, a cross-linked fibrin degradation product, has a high sensitivity in patients with suspected venous thrombosis. Traditional latex D-dimer assays, however, have not been sufficiently sensitive to exclude venous thromboembolism...
  9. ncbi request reprint Imaging characteristics of a novel technetium Tc 99m-labeled platelet glycoprotein IIb/IIIa receptor antagonist in patients With acute deep vein thrombosis or a history of deep vein thrombosis
    Shannon M Bates
    Thromboembolism Unit Office, HSC 3W11, Department of Medicine, McMaster University Medical Centre, 1200 Main St W, Hamilton, Ontario, Canada L8N 3Z5
    Arch Intern Med 163:452-6. 2003
    ....
  10. ncbi request reprint Treatment and prophylaxis of venous thromboembolism during pregnancy
    Shannon M Bates
    Thromboembolism Unit Office, HSC 3W11, Department of Medicine, McMaster University Medical Centre, 1200 Main Street West, Hamilton, Ontario, Canada L8N 3Z5
    Thromb Res 108:97-106. 2002
    ..This paper briefly reviews the areas of controversy and provides recommendations for the treatment and prophylaxis of acute deep vein thrombosis and pulmonary embolism in pregnant patients...
  11. ncbi request reprint Clinical practice. Treatment of deep-vein thrombosis
    Shannon M Bates
    Department of Medicine, McMaster University, Hamilton, Ont, Canada
    N Engl J Med 351:268-77. 2004
  12. ncbi request reprint A diagnostic strategy involving a quantitative latex D-dimer assay reliably excludes deep venous thrombosis
    Shannon M Bates
    McMaster University Medical Centre, HSC 3W11, 1200 Main Street West, Hamilton, Ontario L8N 3Z5, Canada
    Ann Intern Med 138:787-94. 2003
    ..Because clinical diagnosis is inaccurate, objective testing is usually considered necessary when patients present with suspected deep venous thrombosis (DVT)...
  13. ncbi request reprint Use of a fixed activated partial thromboplastin time ratio to establish a therapeutic range for unfractionated heparin
    S M Bates
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Arch Intern Med 161:385-91. 2001
    ..We sought to identify an aPTT ratio that corresponds to therapeutic anti--factor Xa heparin levels for combinations of several reagents and coagulometers that are commonly used...
  14. doi request reprint Pregnancy-associated venous thromboembolism: prevention and treatment
    Shannon M Bates
    Department of Medicine, McMaster University and Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada
    Semin Hematol 48:271-84. 2011
    ..This article reviews the available literature and provides guidance for the management and prevention of VTE during pregnancy...
  15. ncbi request reprint An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trial
    Clive Kearon
    McMaster University and the Henderson Research Centre, Hamilton, Ontario, Canada
    Ann Intern Med 144:812-21. 2006
    ..It may be safe to omit additional diagnostic testing in selected patients with suspected pulmonary embolism (PE) who have a negative D-dimer test, but this approach has never been evaluated in a randomized, controlled trial...
  16. ncbi request reprint Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians
    Jennifer A Pereira
    Centre for Evaluation of Medicines, St Joseph s Healthcare, Hamilton, ON
    Can J Clin Pharmacol 12:e229-39. 2005
    ..The issue of therapeutic equivalence has been a source of controversy in Canada since the approval of generic warfarin products in 2000...
  17. ncbi request reprint 2009 evidence-based clinical practice guidelines for diagnosing a first episode of lower extremities deep vein thrombosis in ambulatory outpatients
    Roman Jaeschke
    Department of Medicine, McMaster University, Hamilton, Canada
    Pol Arch Med Wewn 119:541-9. 2009
    ..The framework mandates explicit evidence summaries, ratings of the quality of evidence, and specifying recommendations as strong or weak...
  18. ncbi request reprint The status of new anticoagulants
    Shannon M Bates
    Department of Medicine, McMaster University, ON, Canada
    Br J Haematol 134:3-19. 2006
    ..This paper reviews the pharmacology of these new agents and describes the results of clinical trials with new anticoagulants in more advanced stages of clinical testing...
  19. ncbi request reprint "ProC Global": a functional screening test that predicts recurrent venous thromboembolism
    Anne Grand'Maison
    Department of Medicine, University of Toronto, Ontario, Canada
    Thromb Haemost 93:600-4. 2005
    ..04). These results suggest that ProC Global may serve as a predictor of recurrent VTE and potentially for first episode of idiopathic VTE. ProC Global may help identify patients at increased risk of initial and recurrent VTE...
  20. ncbi request reprint Coagulation assays
    Shannon M Bates
    Department of Medicine, McMaster University, Henderson Research Centre, Hamilton, Ontario, Canada
    Circulation 112:e53-60. 2005
  21. doi request reprint Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trial
    Lori Ann Linkins
    McMaster University, Hamilton, Ontario, Canada
    Ann Intern Med 158:93-100. 2013
    ..Changing the use of testing and the threshold level for a positive test result on the basis of risk for DVT might improve the tradeoff between sensitivity and specificity and reduce the need for testing...
  22. ncbi request reprint Low-dose warfarin in rehabilitating stroke survivors
    Jeffrey S Ginsberg
    Department of Medicine, McMaster University Medical Centre, 1200 Main Street West Rm 3X28, Hamilton, Ontario L8N 3Z5, Canada
    Thromb Res 107:287-90. 2002
    ..0-3.0 is effective for the prevention of VTE. However, because stroke is a major risk factor for bleeding with warfarin, a less intense regimen (target INR < 2.0), might safely prevent VTE in stroke rehabilitation patients...
  23. ncbi request reprint Anticoagulation of pregnant women with mechanical heart valves
    Jeffrey S Ginsberg
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Arch Intern Med 163:694-8. 2003
    ..We believe a consensus conference among experts in the field to identify key unresolved issues and a commitment by the FDA and industry to perform appropriate studies are now critical...
  24. doi request reprint The effect of prothrombotic blood abnormalities on risk of deep vein thrombosis in users of hormone replacement therapy: a prospective case-control study
    Jim D Douketis
    Department of Medicine, McMaster University, Hamilton, Canada
    Clin Appl Thromb Hemost 17:E106-13. 2011
    ..Few studies have assessed the effect of prothrombotic blood abnormalities on the risk of deep vein thrombosis (DVT) with hormone replacement therapy (HRT)...
  25. ncbi request reprint Are brand-name and generic warfarin interchangeable? Multiple n-of-1 randomized, crossover trials
    Jennifer A Pereira
    Centre for Evaluation of Medicines, St Joseph s Healthcare, Hamilton, Ontario, Canada
    Ann Pharmacother 39:1188-93. 2005
    ..Warfarin is a commonly used anticoagulant in North America. Several generic formulations have been approved, raising concern over the safety and efficacy of these products compared with brand-name Coumadin...
  26. ncbi request reprint Pregnancy and deep vein thrombosis
    S M Bates
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Semin Vasc Med 1:97-104. 2001
    ..This article briefly reviews the areas of controversy and provides recommendations for the treatment of acute DVT and thromboprophylaxis in pregnant patients...
  27. doi request reprint Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study
    James D Douketis
    Dept of Medicine, McMaster University, Hamilton, ON, Canada
    Thromb Res 130:381-9. 2012
    ..This test has an anatomic component to locate DVT and a functional component to differentiate acute (newly formed) thrombus from inactive (old) thrombus...
  28. doi request reprint Accuracy and usefulness of a clinical prediction rule and D-dimer testing in excluding deep vein thrombosis in cancer patients
    Marc Carrier
    Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Thromb Res 123:177-83. 2008
    ....
  29. ncbi request reprint A randomized trial of diagnostic strategies after normal proximal vein ultrasonography for suspected deep venous thrombosis: D-dimer testing compared with repeated ultrasonography
    Clive Kearon
    McMaster University and the Henderson Research Centre, Hamilton, Ontario, Canada
    Ann Intern Med 142:490-6. 2005
    ..With suspected deep venous thrombosis and normal results on proximal vein ultrasonography, a negative d-dimer result may exclude thrombosis and a positive D-dimer result may be an indication for venography...
  30. ncbi request reprint How we manage venous thromboembolism during pregnancy
    Shannon M Bates
    Department of Medicine, McMaster University, Hamilton, ON, Canada
    Blood 100:3470-8. 2002
    ..A recent study has demonstrated that for women with a single episode of prior VTE, many can be managed without anticoagulants. However, for many, anticoagulant therapy with prophylactic UFH or LMWH is a reasonable option...
  31. pmc New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin
    Shannon M Bates
    Department of Medicine, McMaster University and Henderson Research Centre, Hamilton, Ontario, Canada
    Br J Pharmacol 144:1017-28. 2005
    ..After a brief review of thrombogenesis and its regulation, this paper focuses on new anticoagulant agents in more advanced stages of clinical testing...
  32. ncbi request reprint Should D-dimer testing be used to predict the risk of recurrence after discontinuation of anticoagulant therapy for a first unprovoked episode of venous thromboembolism?
    Cynthia Wu
    Department of Medicine, McMaster University and Henderson Research Centre, Hamilton, ON, Canada
    Pol Arch Med Wewn 119:225-30. 2009
    ..This paper reviews recent data surrounding the use of D-dimer to predict the risk of recurrent venous thromboembolism and how this test may help streamline decisions regarding duration of therapy...
  33. doi request reprint Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis
    Ignacio Neumann
    McMaster University Health Sciences Centre, Clinical Epidemiology and Biostatistics, Room 2C12, 1280 Main Street West, Hamilton, Ontario L8S 4K1, Canada
    Ann Intern Med 156:710-9. 2012
    ..Thromboembolic disease is the most frequent medical complication of arthroplasty...
  34. pmc A population-based study of inferior vena cava filters in patients with acute venous thromboembolism
    Frederick A Spencer
    Department of Medicine, Divisions of Cardiology and Hematology Thrombosis, Faculty of Health Sciences, McMaster University, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada
    Arch Intern Med 170:1456-62. 2010
    ....
  35. ncbi request reprint Acute coronary syndromes: a focus on thrombin
    Jeffrey I Weitz
    Department of Medicine, McMaster University and Henderson Research Centre, Hamilton, Ontario, Canada
    J Invasive Cardiol 14:2B-7B. 2002
  36. pmc Criteria for evaluating evidence that laboratory abnormalities are associated with the development of venous thromboembolism
    S M Bates
    Department of Medicine, McMaster University, Hamilton, Ont
    CMAJ 163:1016-21. 2000
    ..Criteria for determining whether specific laboratory abnormalities have a relationship with venous thromboembolism are proposed here, and one example of the application of these guidelines is provided...
  37. ncbi request reprint Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study
    J D Douketis
    Department of Medicine, McMaster University, Hamilton, Canada
    J Thromb Haemost 3:943-8. 2005
    ..Although hormone replacement therapy (HRT) is associated with an increased risk of deep vein thrombosis (DVT), it is not clear if the risk differs in users of combined estrogen-progestin HRT and estrogen-only HRT...
  38. ncbi request reprint Management of venous thromboembolism during pregnancy
    J S Ginsberg
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    J Thromb Haemost 1:1435-42. 2003
    ..Depending on the presence of one or both of these factors, clinical surveillance, with anticoagulant treatment where necessary, is recommended...
  39. ncbi request reprint Decrease in sensitivity of D-dimer for acute venous thromboembolism after starting anticoagulant therapy
    F Couturaud
    Hamilton Civic Hospitals Research Centre, and McMaster University, Hamilton, Ontario, Canada
    Blood Coagul Fibrinolysis 13:241-6. 2002
    ..0-98.6) to 89.4% (95% confidence interval, 83.7-95.1). There is a decrease in D-dimer levels in patients with acute VTE 24 h after starting heparin therapy that is expected to result in a clinically important drop in sensitivity...
  40. doi request reprint Human-derived D-dimer for external quality assessment: results of four surveys in Ontario
    Mark A Crowther
    Hamilton Regional Laboratory Medicine Program, St Joseph s Hospital, McMaster University, Hamilton, Canada
    Am J Clin Pathol 130:805-10. 2008
    ..0%-1.5%), 2.3% (CI, 0.5%-6.6%), and 2.3% (CI, 0.4%-6.6%) of participants reporting an incorrect result in the first, second, third, and fourth surveys, respectively. A commercially prepared D-dimer is a suitable material for EQA testing...
  41. doi request reprint Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis
    Khalid A Alsaleh
    Department of Medicine, Michael G DeGroote School of Medicine McMaster University, Hamilton, Ontario, Canada
    Am J Hematol 83:876-8. 2008
    ..Confirmed delayed-onset HIT with LMWH has not been previously reported. Low dose fondaparinux does not necessarily prevent thrombotic complications of HIT...
  42. ncbi request reprint Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patients
    M A Crowther
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Intensive Care Med 31:48-55. 2005
    ..Tests that might be useful for these applications include markers of hypercoagulability (predicting patients at risk of DVT) and D-dimer (predicting which patients may have acute DVT)...
  43. ncbi request reprint Emerging anticoagulant drugs
    Shannon M Bates
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Arterioscler Thromb Vasc Biol 23:1491-500. 2003
    ..After a brief review of thrombogenesis and its regulation, this study focuses on new anticoagulant agents in more advanced stages of clinical testing...
  44. doi request reprint Preventing thrombophilia-related complications of pregnancy
    Nina Raju
    Department of Medicine, McMaster University, Hamilton General Hospital, 237 Barton Street East, Hamilton, Ontario, Canada
    Expert Rev Hematol 2:183-96. 2009
    ....
  45. ncbi request reprint Use of different D-dimer levels to exclude venous thromboembolism depending on clinical pretest probability
    L A Linkins
    Department of Medicine, Henderson Research Center, McMaster University, Hamilton, Canada
    J Thromb Haemost 2:1256-60. 2004
    ..Use of three pretest probability-specific D-dimer cut-off points rather than a single D-dimer cut-off point for all patients, has the potential to increase the utility of D-dimer testing for the diagnosis of venous thromboembolism...
  46. ncbi request reprint New anticoagulants
    J I Weitz
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    J Thromb Haemost 3:1843-53. 2005
    ..After a brief review of coagulation pathways, this paper focuses on new anticoagulants in advanced stages of clinical testing...
  47. ncbi request reprint Clinical trials that have influenced the treatment of venous thromboembolism: a historical perspective
    J Hirsh
    Hamilton Civic Hospitals Research Centre, Henderson Division, 711 Concession Street, Hamilton, Ontario L8V 1C3, Canada
    Ann Intern Med 134:409-17. 2001
    ..The studies are discussed from a historical perspective, and an attempt is made to analyze both the thought processes that prompted their design and the reasons why they changed practice...
  48. doi request reprint Nonheparin anticoagulants for heparin-induced thrombocytopenia
    John G Kelton
    From the Department of Medicine, Michael G DeGroote School of Medicine, McMaster University J G K, D M A, S M B Canadian Blood Services D M A and the Thrombosis and Atherosclerosis Research Institute S M B all in Hamilton, ON, Canada
    N Engl J Med 368:737-44. 2013
    ..Several agents are in clinical use for this condition, including parenteral direct thrombin inhibitors and parenteral factor Xa inhibitors...
  49. doi request reprint D-dimer testing is useful to exclude deep vein thrombosis in elderly outpatients
    M Carrier
    Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada
    J Thromb Haemost 6:1072-6. 2008
    ..Deep vein thrombosis (DVT) can be safely and reliably excluded in patients with a low clinical probability and a negative D-dimer result but the accuracy and utility of such a strategy is unclear in elderly patients...
  50. doi request reprint Differences in clinical presentation of deep vein thrombosis in men and women
    E Roseann Andreou
    McMaster University, Henderson Research Centre, Hamilton, ON, Canada
    J Thromb Haemost 6:1713-9. 2008
    ..As assessment of clinical pretest probability is the first step in the diagnostic evaluation of deep vein thrombosis (DVT), it is important to know if the clinical features of DVT are the same in men and women...
  51. ncbi request reprint Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    Shannon M Bates
    McMaster University Medical Center, 1200 Main St West, Hamilton, ON L8N 325
    Chest 126:627S-644S. 2004
    ..In high-risk women with prosthetic heart valves, we suggest the addition of low-dose aspirin, 75 to 162 mg/d (Grade 2C)...